Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

358
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
358
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

48
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
48

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association of healthy lifestyle with incident cardiovascular diseases in individuals with type 1 diabetes mellitus: a prospective cohort study.

Diabetology & metabolic syndrome·2026
Same author

Integrated anthropometric correlates of planned change-of-direction performance (T-test) in male badminton players: a partial least squares regression study.

Frontiers in physiology·2026
Same author

Concurrent control of natural and robotic limbs through a tactile-encoded brain-computer interface.

Nature communications·2026
Same author

Jasmonate, salicylate, and ethylene-responsive transcriptomics discovery in spikelets of three wheat genotypes reveals a rapid and conserved response for jasmonate signaling.

Plant signaling & behavior·2026
Same author

Assessing different Protein A resins' homodimer separation potentials through processing a two-antibody-containing artificial mixture.

Protein expression and purification·2026
Same author

Reply to "Letter to the editor: methodological considerations in the benchmarking of AI-based protein-aptamer complex prediction".

Briefings in bioinformatics·2026

相关实验视频

Updated: Jun 24, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K

整合变压器和多目标优化用于药物设计.

Nicholas Aksamit1, Jinqiang Hou2,3, Yifeng Li4,5

  • 1Department of Computer Science, Brock University, 1812 Sir Isaac Brock Way, St. Catharines, ON, L2S 3A1, Canada.

BMC bioinformatics
|June 7, 2024
PubMed
概括

这项研究引入了用于药物设计的新型AI框架,集成了变压器模型和多目标优化. 它有效地识别出具有高结合亲和力,低毒性和良好的药物相似性的候选药物,用于与癌症相关的标.

关键词:
接收人 接收人药物设计 药物设计进化算法是一种进化算法.在LPA1中,LPA1是LPA1.多目标优化优化分子生成分子生成粒子群集优化优化 粒子群集优化变压器 变压器 变压器

更多相关视频

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
07:08

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues

Published on: July 14, 2015

7.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

相关实验视频

Last Updated: Jun 24, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K
Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
07:08

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues

Published on: July 14, 2015

7.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

科学领域:

  • 药物发现中的计算化学和人工智能.

背景情况:

  • 药物设计需要针对特定蛋白质的新分子,这是一个复杂的过程.
  • 人工智能 (AI) 在加速药物设计方面表现有前途,但往往面临着多重目标的局限性.
  • 现有的多目标方法限制了优化目标的数量.

研究的目的:

  • 从多个目标的角度开发一种用于药物设计的新型AI框架.
  • 将先进的分子生成模型与全面的药物设计预测和优化技术相结合.
  • 探索基于变压器的模型和多目标元启发学在识别有效药物候选者的有效性.

主要方法:

  • 一个框架结合了潜在的变压器模型 (ReLSO或FragNet) 进行分子生成.
  • 吸收,分布,新陈代谢,分泌和毒性 (ADMET) 预测,分子对接和多目标元启发的整合.
  • 对ReLSO和FragNet进行分子生成性能的比较分析.
  • 在药物设计任务中对六个多目标元启发的评估,该任务针对人体溶解酸受体 1.

主要成果:

  • 在分子重建和潜伏空间组织方面,ReLSO在FragNet上表现出优越的性能.
  • 该研究确定了基于主导和分解的多目标进化算法是最有效的.
  • 这种算法成功地发现了具有高结合亲和力,低毒性和高药物相似性的分子.

结论:

  • 拟议的框架有效地将变压器模型与用于先进药物设计的多目标计算智能相结合.
  • 这些发现突出了这种综合方法在发现强效和安全的候选药物的潜力.
  • 这项研究通过在更多关键药物设计目标中实现优化,使该领域取得了进展.